← Back to patent-cliff list

CAS 124266-10-0

(2R,3S,4R)-5-(1,3-dioxan-2-yl)pentane-1,2,3,4-tetraol

Codes: 2-Deoxyglucose-003

Application context (from source-drug indications)

Seizure2-DeoxyglucoseOverweight2-DeoxyglucoseNon-alcoholic steatohepatitis2-DeoxyglucoseObesity2-Deoxyglucose糖尿病前期2-DeoxyglucoseInsulin resistance2-Deoxyglucose

Source drugs (routes using this intermediate)

DrugTierExpiry
2-DeoxyglucoseTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

2-DeoxyglucoseOptimised routesteps: 3total yield: /
(3S,4R)-5-(1,3-dioxan-2-yl)-1,3,4-trihydroxypentan-2-one→(3S,4R)-5-(1,3-dioxan-2-yl)pentane-1,2,3,4-tetraol→(2R,3S,4R)-5-(1,3-dioxan-2-yl)pentane-1,2,3,4-tetraol→D-arabino-Hexose, 2-deoxy-

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.